Susquehanna International Group
BIOTW

Susquehanna International Group’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Susquehanna International Group’s Portfolio BIOTW Stock Details BIOTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,328
Closed -$660 – 14153
2022
Q4 		$660 Buy
+10,328
New +$395 ﹤0.01% 12197
2022
Q2 		– Sell
-15,354
Closed -$4K – 14410
2022
Q1 		$4K Sell
15,354
-10,331
-40% -$3.29K ﹤0.01% 12839
2021
Q4 		$17K Sell
25,685
-4,544
-15% -$3.15K ﹤0.01% 12860
2021
Q3 		$20K Hold
30,229
– – ﹤0.01% 12551
2021
Q2 		$26K Buy
+30,229
New +$21K ﹤0.01% 12405

Susquehanna International Group's BIOTW Position: Q1 2023 in Review

Susquehanna International Group sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 10,328 shares — an estimated $660 sold.

Susquehanna International Group first reported a position in BIOTW in Q2 2021 and held it in 5 quarters. The position peaked at $26K in Q2 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

  • Susquehanna International Group reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 10,328 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $660.
  • Susquehanna International Group first reported a position in Biotech Acquisition Company Warrant in Q2 2021 and held it in 5 quarters.
  • Susquehanna International Group's Biotech Acquisition Company Warrant position peaked at $26K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.